Topic - Novavax

Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX". - Source: Wikipedia

Related Stories

A kidney dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use at a vaccination center in Prisdorf, Germany, Saturday, Feb. 26, 2022. On Tuesday, July 19, 2022, a U.S. Centers for Disease Control and Prevention advisory panel recommended the shots and final action will come from the agency's director. (Georg Wendt/dpa via AP) **FILE**

CDC panel clears Novavax shots, paving way for fourth COVID-19 vaccine to reach U.S. arms

By Tom Howell Jr. - The Washington Times

In this file photo, a vial of the Phase 3 Novavax coronavirus vaccine prepared for use in a trial at St. George's University hospital in London, Oct. 7, 2020. The Food and Drug Administration authorized the COVID-19 vaccine from Novavax for emergency use on Wednesday, July 13, 2022, providing the U.S. with a fourth option. (AP Photo/Alastair Grant) **FILE**

FDA authorizes Novavax COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. The U.S. Food and Drug Administration is evaluating a more traditional kind of vaccine made by Novavax, which the company hopes can win over unvaccinated people and become a top choice for boosters. (Serum Institute of India for Novavax via AP)

FDA advisers endorse Maryland company’s COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

In this Wednesday, Oct. 7, 2020, photo, a Phase 3 Novavax coronavirus vaccine trial volunteer is given an injection at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant) **FILE**

Novavax vaccine poised to be a fourth COVID-19 option in U.S.

By Tom Howell Jr. - The Washington Times

A vial of the Phase 3 Novavax coronavirus vaccine is prepared for use in a trial at St. George's University hospital in London, Oct. 7, 2020. In a statement on Thursday March 31, 2022, the pharmaceutical Novavax said it asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent. (AP Photo/Alastair Grant, File)

Novavax asks EU regulator to clear COVID-19 vaccine for teens

Associated Press

Kidney dishes with mounted syringes containing vaccines, from top, Novavax, Biontech and Moderna sit in a refrigerator in a vaccination center ready for vaccination in Prisdorf, Germany, Saturday, Feb. 26, 2022. Even with vaccine supplies improving, some officials were eagerly awaiting the Novavax vaccine in particular because it is easier to transport and store than some other coronavirus shots. (Georg Wendt/dpa via AP, File)

Rich countries getting new COVID vaccine before poorer ones

By Maria Cheng and Aniruddha Ghosal - Associated Press

An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on April 20, 2021. The European Union’s drugs regulator was meeting Monday, Dec. 20, 2021, to consider giving the green light to a fifth COVID-19 vaccine for use in the 27-nation bloc by granting conditional marketing authorization to the two-dose vaccine made by U.S. biotech company Novavax. (AP Photo/Peter Dejong, File)

EU approves 5th COVID-19 vaccine for bloc, one by Novavax, a Maryland company

By Mike Corder - Associated Press

The French vaccine startup Valneva headquarters is pictured in Saint-Herblain, western France, Wednesday, Feb. 3, 2021. French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate. The buyer? The United Kingdom — not the European Union, as might be expected for a company on the banks of the Loire. (AP Photo/David Vincent)

French drugmaker Valneva reports positive COVID-19 vaccine results

By Tom Howell Jr. - The Washington Times

In this Wednesday, Oct. 7, 2020, photo, a Phase 3 Novavax coronavirus vaccine trial volunteer is given an injection at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant) **FILE**

Maryland company announces another successful COVID vaccine

By James Varney - The Washington Times

In this Wednesday, Oct. 7, 2020, photo, a Phase 3 Novavax coronavirus vaccine trial volunteer is given an injection at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant) **FILE**

Novavax: Large study finds COVID-19 shot about 90% effective

By Linda A. Johnson - Associated Press

An employee works inside a laboratory at the Serum Institute of India, the world's largest vaccine maker, in Pune, India, Thursday, Jan. 21, 2021. The company is a key supplier for the U.N.-backed COVAX program that aims to distribute vaccines equitably in the world. On March 25, COVAX announced a major setback in its vaccine rollout because a surge in infections in India had caused the Serum Institute of India to cater to domestic demand, resulting in a delay in global shipments of up to 90 million doses. (AP Photo/Rafiq Maqbool)

Indian vaccine maker asks US to ease export curbs

By ANIRUDDHA GHOSAL - Associated Press

Vials of AstraZeneca's COVISHIELD vaccine for COVID-19 are seen at a filling lab at the Serum Institute of India, Pune, India, Thursday, Jan. 21, 2021. Experts say there is a pressing need for India to bolster vaccination, which started sluggishly in January. The country is expanding its drive to include everyone over 45 from Thursday, April 1. Spotlight on Serum Institute of India - the world’s largest maker of vaccines and key global supplier - to cater to cases at home has resulted in delays of global shipments of up to 90 million doses under the U.N.-backed COVAX program, an initiative devised to give countries access to vaccines regardless of their wealth. (AP Photo/Rafiq Maqbool)

AP Interview: India could resume vaccine exports by June

By ANIRUDDHA GHOSAL - Associated Press

President Joe Biden steps away from the podium as he speaks during a news conference in the East Room of the White House, Thursday, March 25, 2021, in Washington. (AP Photo/Evan Vucci)

Aid groups call on Biden to develop plans to share vaccines

By ZEKE MILLER - Associated Press

A healthcare worker administers a dose of the AstraZeneca COVID-19 vaccine to a woman at the Brussels Expo center in Brussels, Thursday, March 4, 2021. The Expo is one of the largest vaccination centers in Belgium. (AP Photo/Olivier Matthys)

Conflict grows between US and allies over vaccine supply

By ZEKE MILLER, RAF CASERT and and SAMUEL PETREQUIN - Associated Press

A pharmacist fills a syringe with the Pfizer-BioNTech COVID-19 vaccines at a pop-up vaccination site at the God's Battalion of Prayer Church, Wednesday, Feb. 3, 2021, in the Brooklyn borough of New York. SOMOS and Elderplan volunteer nurses are expected to vaccinate up to 500 older New Yorkers who attend the church or live in surrounding areas. (AP Photo/Mary Altaffer)

145 countries to receive COVID-19 shots for vulnerable groups

By Shen Wu Tan - The Washington Times